TS
LIAN

Thomas Steyer’s LianBio American Depositary Shares LIAN Stock Holding History

Thomas Steyer’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500,000
Closed -$1.08M – 322
2022
Q2 		$1.08M Buy
+500,000
New +$1.7M 0.01% 215
2022
Q1 		– Sell
-600,000
Closed -$3.7M – 336
2021
Q4 		$3.7M Buy
+600,000
New +$6.85M 0.02% 196

Other funds holding LIAN

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $2.48B AUM 8.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Thomas Steyer's LIAN Position: Q3 2022 in Review

Thomas Steyer sold out of LianBio American Depositary Shares (LIAN) in Q3 2022, closing a stake of 500,000 shares — an estimated $1.08M sold.

Thomas Steyer first reported a position in LIAN in Q4 2021 and held it in 2 quarters. The position peaked at $3.7M in Q4 2021. 44 funds tracked by Wall St. Rank hold LIAN as of Q3 2022.

  • Thomas Steyer reported no remaining LianBio American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Thomas Steyer sold 500,000 LianBio American Depositary Shares shares in Q3 2022, an estimated $1.08M.
  • Thomas Steyer first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Thomas Steyer's LianBio American Depositary Shares position peaked at $3.7M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2022.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.